Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro

Abstract

The effect of doxycycline, obtained from human volunteers administered doxycycline, on the minimum inhibitory concentration (MIC) of atovaquone was determined against the K1 and FC27 isolates of Plasmodium falciparum in vitro. Doxycycline concentrations ranging from 0.10-1.18 μg/ml added to atovaquone produced MIC ratios [atovaquone + doxycycline/atovaquone alone] ranging from 0.38 to 0.70. These results suggest that the antimalarial activity of atovaquone is potentiated by doxycycline. Additionally, these drugs may be rational partners for the treatment and prophylaxis of falciparum malaria.

This is a preview of subscription content, log in to check access.

Author information

Additional information

Received: 4 October 1996 / Accepted: 29 November 1996

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yeo, A., Edstein, M., Shanks, G. et al. Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro. Parasitol Res 83, 489–491 (1997). https://doi.org/10.1007/s004360050285

Download citation

Keywords

  • Malaria
  • Minimum Inhibitory Concentration
  • Inhibitory Concentration
  • Plasmodium
  • Doxycycline